Increased Low Density Lipoprotein Particle Numbers in High Versus Low SLE Activity, A Potential Mechanism for Enhanced Cardiovascular Risk

被引：0
|
作者：
Durcan, L. [1 ]
Winegar, D. A. [2 ]
Connelly, M. A. [2 ]
Otvos, J. D. [2 ]
Magder, L. S. [3 ]
Petri, M. [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
[2] Labcorp, Raleigh, NC USA
[3] Univ Maryland, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P5.06
引用
收藏
页码：S39 / S40
页数：2
相关论文
共 50 条
  • [31] Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol
    Lawler, Patrick R.
    Akinkuolie, Akintunde O.
    Chu, Audrey Y.
    Shah, Svati H.
    Kraus, William E.
    Craig, Damian
    Padmanabhan, Latha
    Glynn, Robert J.
    Ridker, Paul M.
    Chasman, Daniel I.
    Mora, Samia
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (07):
  • [32] Fasting non-high-density lipoprotein cholesterol and low-density lipoprotein particle size
    Arisaka, Osamu
    Kariya, Katsura
    Ichikawa, Go
    JOURNAL OF PEDIATRICS, 2012, 160 (03): : 531 - 532
  • [33] Low High-Density Lipoprotein and Risk of Myocardial Infarction
    Ramirez, A.
    Hu, P. P.
    CLINICAL MEDICINE INSIGHTS-CARDIOLOGY, 2015, 9 : 113 - 117
  • [34] THE EFFECT OF THE ANTIESTROGEN TAMOXIFEN ON LOW-DENSITY-LIPOPROTEIN OXIDATION IN POSTMENOPAUSAL WOMEN - A POTENTIAL MECHANISM FOR CARDIOVASCULAR BENEFIT
    GUETTA, V
    CANNON, RO
    CIRCULATION, 1995, 92 (08) : 780 - 780
  • [35] Low Density Lipoprotein Subfractions, Lipoprotein(A), and Cardiovascular Disease Risk Assessment in the Framingham Offspring Study
    Ikezaki, Hiroaki
    Fisher, Virgina A.
    Liu, Ching-ti
    Cupples, L. Adrienne
    Nakajima, Katsuyuki
    Asztalos, Bela F.
    Schaefer, Ernst J.
    CIRCULATION, 2018, 138
  • [36] Low-Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events
    Willeit, Peter
    Yeang, Calvin
    Moriarty, Patrick M.
    Tschiderer, Lena
    Varvel, Stephen A.
    McConnell, Joseph P.
    Tsimikas, Sotirios
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (23):
  • [37] Improving cardiovascular outcomes by intensifying low density lipoprotein lowering therapy in high-risk patients
    Jacoby, Douglas S.
    Rader, Daniel J.
    EUROPEAN HEART JOURNAL, 2016, 37 (48) : 3585 - 3587
  • [38] Upregulation of low-density lipoprotein receptor activity in steroid-resistant nephrotic syndrome treated with low-density lipoprotein apheresis: Clinical efficacy and potential mechanism
    Shima, Hisato
    THERAPEUTIC APHERESIS AND DIALYSIS, 2024, 28 (04) : 516 - 517
  • [39] Usefulness of low-density lipoprotein particle size measurement in cardiovascular disease prevention
    Brook, RD
    Kansal, M
    Bard, RL
    Eagle, K
    Rubenfire, M
    CLINICAL CARDIOLOGY, 2005, 28 (11) : 534 - 537
  • [40] Low-Density Lipoprotein Cholesterol, Cardiovascular Disease Risk, and Mortality in China
    Chen, Liang
    Chen, Shi
    Bai, Xueke
    Su, Mingming
    He, Linkang
    Li, Guangyu
    He, Guangda
    Yang, Yang
    Zhang, Xiaoyan
    Cui, Jianlan
    Xu, Wei
    Song, Lijuan
    Yang, Hao
    He, Wenyan
    Zhang, Yan
    Li, Xi
    Hu, Shengshou
    JAMA NETWORK OPEN, 2024, 7 (07)
12345